StockSelector.com
  Research, Select, & Monitor Thursday, December 14, 2017 7:35:18 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Hill-Rom Holdings, Inc.$81.84($1.31)(1.58%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Hill-Rom Reports Strong Fourth Quarter and Full-Year Results Exceeding Previous Guidance
   Thursday, November 05, 2015 6:00:00 AM ET

Hill-Rom Holdings, Inc. (HRC ) announced financial results for its fourth quarter ended September 30, 2015, and its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.89 increased 20 percent from $0.74 in the prior year. The reported loss per diluted share was $0.16 as compared to income of $0.42 in the prior year, reflecting acquisition and integration expenses, restructuring expenses and other items excluded from adjusted earnings. Adjustments to reported earnings are detailed in the reconciliation schedules provided.

http://photos.prnewswire.com/prnvar/20130123/DE47178LOGO

Hill-Rom’s quarterly revenue of $574 million increased 20 percent compared to last year, or 25 percent on a constant currency basis, primarily due to strong North America capital revenue growth and the Trumpf Medical and Welch Allyn acquisitions. Excluding the benefit of acquisitions, our constant currency growth was 7 percent, driven primarily by 13 percent growth in North America and 6 percent growth in the Surgical and Respiratory Care businesses. Domestic revenue was $384 million, up 26 percent, while revenue outside the United States of $190 million increased 22 percent on a constant currency basis.

For the full year, revenue was $1,988 million compared to $1,686 million for the prior year, an increase of 18 percent on a reported basis and 24 percent on a constant currency basis. Excluding acquisitions, constant currency growth was 7 percent. Adjusted earnings per diluted share for fiscal 2015 were $2.64 compared to $2.25 in 2014, an increase of 17 percent. Reported earnings per diluted share for the full year were $0.82 compared to $1.04 for the prior year.

Management Comments

"We finished the year ahead of our expectations with strong fourth quarter results that included a 20 percent increase in adjusted earnings and constant currency revenue growth of 7 percent, excluding acquisitions," said John Greisch, Hill-Rom President and Chief Executive Officer. "Our ongoing focus on margin expansion resulted in a significant increase in adjusted operating margin of 220 basis points for the quarter. For the full year, we delivered record adjusted earnings of $2.64 per diluted share, a 17 percent increase."

Greisch continued, "We are very pleased with the progress we made in 2015 on a number of fronts. We strengthened our management team with several key appointments during the year and we significantly enhanced our portfolio with the additions of Trumpf Medical and Welch Allyn. Together with new product introductions and our continued focus on operational excellence, we have improved our customer value proposition and are driving strong growth in revenue and adjusted earnings for 2016 and beyond."

Fourth Quarter Financial Highlights

Revenue:

North America. North America revenue increased 12 percent to $278 million. On a constant currency basis, capital sales increased 13 percent, while rental revenue increased 14 percent. Strong sales of our Progressa ICU bed system and Clinical Workflow Solutions led capital sales growth while incremental volume drove rental growth.

Surgical/Respiratory Care. Surgical and Respiratory Care revenue increased 32 percent to $141 million, or 40 percent on a constant currency basis. Excluding Trumpf Medical, constant currency growth was 6 percent.

International. International segment revenue of $106 million was down 5 percent on a constant currency basis and 16 percent on a reported basis. On a constant currency basis, capital revenue was down nearly 5 percent compared to the prior year, while rental revenue decreased 11 percent.

Welch Allyn. Welch Allyn revenue was $50 million for the period following the close of the transaction on September 8, 2015.

Adjusted operating margin increased 220 basis points to 14.6 percent reflecting improvement in organic margins as well as accretion from Welch Allyn.

Excluding net cash outflows of $21 million associated with the Welch Allyn transaction, full year operating cash flow of $235 million compares to $210 million in the prior year.

Please see the attached schedules for additional information and reconciliations of GAAP to adjusted financial measures.

For a more complete review of Hill-Rom’s results, please refer to the Company’s Annual Report on Form 10-K for the year ended September 30, 2015, which will be filed later this month.

Financial Guidance Summary

Revenue: For fiscal 2016, Hill-Rom expects reported revenue to be between $2.66 and $2.70 billion. This reflects:

-- low to mid-single-digit constant currency organic growth;

-- 3 to 5 percent pro-forma constant currency growth from Welch Allyn; and

-- negative currency impact of 1 to 2 percent at current rates.

For the first quarter of fiscal 2016, Hill-Rom expects reported revenue to be between $645 and $655 million. This reflects:

-- low to mid-single-digit constant currency organic growth;

-- revenue contribution from Welch Allyn; and

-- negative currency impact of 3 to 4 percent at current rates.

Adjusted Earnings per Diluted Share: The Company expects full year adjusted earnings per diluted share to be $3.08 to $3.14.

First quarter adjusted earnings per diluted share are expected to be $0.60 to $0.62.

Cash Flow: Hill-Rom expects cash flow from operations for the full year to be approximately $300 million, which includes non-recurring outflows related to our ongoing restructuring and integration activities. Capital expenditures are expected to be approximately $110 to $120 million.

Discussion of Adjusted Financial Measures

Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company’s management believes that the presentation provides useful information to investors. This measure excludes strategic developments, acquisition and integration costs, special charges or other unusual events. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company’s reported operations for a period. Often, prospective quantification of such items is not feasible.

The Company also excludes expenses associated with the amortization of intangible assets associated with prior business acquisitions. This adjustment is made to allow investors to evaluate and understand operating trends excluding the non-cash impact of acquired intangible amortization on operating income, earnings per share and other measures.

Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Reconciliations of GAAP measures to adjusted measures appear in the financial tables of this release.

Conference Call Webcast and Dial-in Information

As previously announced, the Company will host a conference call and webcast today at 8:00 a.m. ET.

Webcast: To join the live webcast with audio, go to http://ir.hill-rom.com/events.cfm or http://edge.media-server.com/m/p/xayzvqsu . The webcast slide deck will be posted to the Hill-Rom website prior to the webcast.

Conference Call Audio Only Dial-in information: To join the live conference call, dial 877-304-8969 domestic callers / 631-291-4543 international callers. The following Confirmation Code is required for both: 51202184. Callers will need to provide their name, company affiliation and telephone number to the conference operator. A recording of the webcast/call audio will be available for telephone replay through November 10, 2015, domestically at 855-859-2056 and internationally at 404-537-3406. For the replay, callers will need to use confirmation code 51202184. If you are unable to listen to the live webcast or the telephone replay, the webcast will be archived at http://ir.hill-rom.com/events.cfm

About Hill-Rom Holdings, Inc.

Hill-Rom is a leading global medical technology company with approximately 10,000 employees worldwide. We partner with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. Around the world, Hill-Rom’s people, products, and programs work towards one mission: Enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Disclosure Regarding Forward Looking Statements

Certain statements herein contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company’s future plans, objectives, beliefs, expectations, representations and projections. It is important to note that forward-looking statements are not guarantees of future performance, and the Company’s actual results could differ materially from those set forth in any forward-looking statements. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company’s previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or revise any forward-looking statements.

Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Income (Loss)
(Dollars in millions, except per share data)
                                                         Quarter Ended September 30                         Year Ended September 30
                                                         2015                      2014                     2015                     2014
Net revenue
Capital sales                                            $                478.6    $                389.5   $             1,604.5    $             1,301.4
Rental revenue                                           95.3                      90.3                     383.7                    384.7
Total revenue                                            573.9                     479.8                    1,988.2                  1,686.1
Cost of revenue
Cost of goods sold                                       268.9                     221.3                    921.2                    730.2
Rental expenses                                          48.3                      45.2                     186.7                    176.0
Total cost of revenue                                    317.2                     266.5                    1,107.9                  906.2
Gross profit
Capital                                                  209.7                     168.2                    683.3                    571.2
Rental                                                   47.0                      45.1                     197.0                    208.7
Total gross profit                                       256.7                     213.3                    880.3                    779.9
As a percentage of sales                                 44.7%                     44.5%                    44.3%                    46.3%
Research and development expenses                        24.5                      21.6                     91.8                     71.9
Selling and administrative expenses                      208.7                     151.6                    664.2                    548.3
Special charges                                          29.3                      4.7                      41.2                     37.1
Operating profit (loss)                                  (5.8)                     35.4                     83.1                     122.6
Other income/(expense), net                              (10.7)                    (1.2)                    (18.0)                   (7.4)
Income tax expense (benefit)                             (6.4)                     9.6                      18.3                     54.6
Net income (loss)                                        (10.1)                    24.6                     46.8                     60.6
Less:  Net loss attributable to noncontrolling interests (0.5)                     -                        (0.9)                    -
Net income (loss) attributable to common shareholders    $                  (9.6)  $                  24.6  $                  47.7  $                  60.6
Diluted earnings per share:
Earnings per share                                       $                 (0.16)  $                  0.42  $                  0.82  $                  1.04
Average common shares outstanding - diluted (thousands)  58,708                    58,426                   58,536                   58,523
Dividends per common share                               $              0.1600     $              0.1525    $              0.6325    $              0.5950

Non-GAAP Financial Disclosures and Reconciliations

While Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. Hill-Rom uses non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

Hill-Rom Holdings, Inc. and Subsidiaries
Revenue - Constant Currency
(Dollars in millions)
                               Quarter Ended September 30
                               2015                    Foreign Exchange          2015                    2014                    Constant Currency
                               As Reported             Impact                    Adjusted                As Reported             Change
Capital sales                  $                478.6  $                 (22.8)  $                501.4  $                389.5  28.7%
Rental revenue                 95.3                    (2.0)                     97.3                    90.3                    7.8%
Total                          $                573.9  $                 (24.8)  $                598.7  $                479.8  24.8%
North America                  $                277.5  $                  (1.9)  $                279.4  $                247.3  13.0%
Surgical and Respiratory Care  140.6                   (8.5)                     149.1                   106.5                   40.0%
International                  105.6                   (13.8)                    119.4                   126.0                   -5.2%
Welch Allyn                    50.2                    (0.6)                     50.8                    -                       N/M
Total                          $                573.9  $                 (24.8)  $                598.7  $                479.8  24.8%
                               Year Ended September 30
                               2015                    Foreign Exchange          2015                    2014                    Constant Currency
                               As Reported             Impact                    Adjusted                As Reported             Change
Capital sales                  $             1,604.5   $                 (86.2)  $             1,690.7   $             1,301.4   29.9%
Rental revenue                 383.7                   (7.6)                     391.3                   384.7                   1.7%
Total                          $             1,988.2   $                 (93.8)  $             2,082.0   $             1,686.1   23.5%
North America                  $             1,002.0   $                  (5.9)  $             1,007.9   $                888.9  13.4%
Surgical and Respiratory Care  506.6                   (31.3)                    537.9                   301.6                   78.3%
International                  429.4                   (56.0)                    485.4                   495.6                   -2.1%
Welch Allyn                    50.2                    (0.6)                     50.8                    -                       N/M
Total                          $             1,988.2   $                 (93.8)  $             2,082.0   $             1,686.1   23.5%
N/M - Not Meaningful
Hill-Rom Holdings, Inc. and Subsidiaries
Reconciliation: Earnings Per Share
(Dollars in millions except per share data)
                                                          Quarter Ended September 30, 2015                                                                               Quarter Ended September 30, 2014
                                                          Operating Margin   Income (Loss) Before Income Taxes  Income Tax Expense (Benefit)  NCI           Diluted EPS  Operating Margin1  Income Before Income Taxes  Income Tax Expense  Diluted EPS1
GAAP Basis                                                -1.0%              $    (16.5)                        $      (6.4)                  $      (0.5)  $    (0.16)  7.4%               $     34.2                  $       9.6         $     0.42
Adjustments:
Acquisition and integration costs                         7.5%               43.3                               11.7                          -             0.53         2.1%               9.9                         2.8                 0.12
Acquisition-related intangible asset amortization         1.9%               10.7                               3.3                           -             0.12         1.6%               7.9                         2.4                 0.09
FDA remediation expenses                                  0.1%               0.8                                0.2                           -             0.01         0.4%               1.7                         0.6                 0.02
Field corrective actions                                  -0.1%              (0.4)                              (0.1)                         -             -            -                  -                           -                   -
Special charges                                           5.1%               29.3                               9.5                           -             0.33         1.0%               4.7                         0.4                 0.07
Supplemental stock compensation charge                    1.1%               6.1                                2.2                           -             0.06         -                  -                           -                   -
Foreign valuation allowance and acquisition dividend tax  -                  -                                  -                             -             -            -                  -                           (0.7)               0.01
Adjusted Basis                                            14.6%              $     73.3                         $     20.4                    $      (0.5)  $     0.89   12.4%              $     58.4                  $     15.1          $     0.74
                                                          Year to Date Ended September 30, 2015                                                                          Year to Date Ended September 30, 2014
                                                          Operating Margin1  Income Before Income Taxes         Income Tax Expense            NCI           Diluted EPS  Operating Margin1  Income Before Income Taxes  Income Tax Expense  Diluted EPS1
GAAP Basis                                                4.2%               $     65.1                         $     18.3                    $      (0.9)  $     0.82   7.3%               $    115.2                  $     54.6          $     1.04
Adjustments:
Acquisition and integration costs                         3.2%               62.8                               18.0                          -             0.76         1.0%               16.3                        5.0                 0.19
Acquisition-related intangible asset amortization         1.7%               34.1                               9.8                           -             0.42         1.7%               28.8                        8.7                 0.34
Employee benefits change                                  -                  -                                  -                             -             -            -0.8%              (13.4)                      (5.1)               (0.14)
FDA remediation expenses                                  0.2%               3.8                                1.2                           -             0.04         0.3%               4.5                         1.7                 0.05
Field corrective actions                                  0.2%               4.5                                1.4                           -             0.05         -0.1%              (1.7)                       (0.6)               (0.02)
Litigation settlements and expenses                       -                  (0.6)                              (0.2)                         -             (0.01)       -                  -                           -                   -
Special charges                                           2.1%               41.2                               10.7                          -             0.52         2.2%               37.1                        10.9                0.45
Supplemental stock compensation charge                    0.3%               6.1                                2.2                           -             0.07         -                  -                           -                   -
Foreign valuation allowance and acquisition dividend tax  -                  -                                  1.9                           -             (0.03)       -                  -                           (20.3)              0.35
Adjusted Basis                                            11.8%              $    217.0                         $     63.3                    $      (0.9)  $     2.64   11.5%              $    186.8                  $     54.9          $     2.25
1Total does not add due to rounding.
NCI = Net loss attributable to noncontrolling interests
Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Dollars in millions)
                                                                September 30, 2015             September 30, 2014
Assets
Current Assets
Cash and cash equivalents                                       $                       192.8  $                         99.3
Trade accounts receivable, net of allowances                    494.7                          411.0
Inventories, net                                                267.4                          176.2
Other current assets                                            186.1                          92.8
Total current assets                                            1,141.0                        779.3
Property, plant and equipment, net                              378.4                          261.5
Intangible assets:
Goodwill                                                        1,610.5                        399.8
Software and other, net                                         1,247.7                        261.1
Other assets                                                    80.0                           49.6
Total Assets                                                    $                    4,457.6   $                    1,751.3
Liabilities
Current Liabilities
Trade accounts payable                                          $                       136.3  $                       112.7
Short-term borrowings                                           58.0                           126.9
Other current liabilities                                       384.5                          202.7
Total current liabilities                                       578.8                          442.3
Long-term debt                                                  2,175.2                        364.1
Other long-term liabilities                                     546.7                          138.4
Total Liabilities                                               3,300.7                        944.8
Total Shareholders’ Equity Attributable to Common Shareholders  1,146.9                        806.5
Noncontrolling Interest                                         10.0                           -
Total Shareholders’ Equity                                      1,156.9                        806.5
Total Liabilities and Shareholders’ Equity                      $                    4,457.6   $                    1,751.3
Hill-Rom Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Dollars in millions)
                                                                                                            Year Ended September 30
                                                                                                            2015                            2014
Operating Activities
                  Net income                                                                                $                         46.8  $                         60.6
                  Adjustments to reconcile net income to net cash provided by
                  operating activities:
                                                 Depreciation                                               73.6                            65.4
                                                 Amortization                                               10.5                            12.2
                                                 Acquisition-related intangible asset amortization          34.1                            28.8
                                                 Provision for deferred income taxes                        (22.3)                          3.9
                                                 Loss on disposal of property, equipment leased to others,
                                                 intangible assets and impairments                          0.5                             7.2
                                                 Pension settlement charge                                  9.6                             -
                                                 Stock compensation                                         25.0                            18.0
                                                 Excess tax benefits from employee stock plans              (3.6)                           0.3
                                                 Change in working capital excluding cash, current debt,
                                                 acquisitions and dispositions:
                                                 Trade accounts receivable                                  (39.7)                          17.1
                                                 Inventories                                                11.0                            9.1
                                                 Other current assets                                       (7.7)                           (2.6)
                                                 Trade accounts payable                                     0.7                             7.0
                                                 Accrued expenses and other liabilities                     53.8                            (12.5)
                                                 Other, net                                                 21.5                            (4.2)
Net cash provided by operating activities                                                                   213.8                           210.3
Investing Activities
                  Capital expenditures and purchases of intangibles                                         (121.3)                         (62.7)
                  Proceeds on sales of property and equipment leased to others                              1.5                             2.4
                  Payment for acquisition of businesses, net of cash acquired                               (1,638.7)                       (239.5)
                  Refund on acquisition of businesses                                                       -                               4.6
                  Other                                                                                     2.1                             0.7
Net cash used in investing activities                                                                       (1,756.4)                       (294.5)
Financing Activities
                  Net change in short-term debt                                                             (0.7)                           (0.2)
                  Borrowings on revolving credit facility                                                   95.0                            252.0
                  Payments on revolving credit facility                                                     (135.0)                         (57.0)
                  Proceeds from long-term debt                                                              2,225.0                         0.8
                  Payment of long-term debt                                                                 (401.6)                         (11.4)
                  Payment of acquired debt                                                                  -                               (26.8)
                  Repurchase of registered debentures                                                       (5.9)                           -
                  Debt issuance costs                                                                       (50.3)                          -
                  Purchase of noncontrolling interest of former joint venture                               (1.9)                           (1.3)
                  Payment of cash dividends                                                                 (37.1)                          (34.2)
                  Proceeds on exercise of stock options                                                     12.1                            11.5
                  Proceeds from stock issuance                                                              2.8                             2.5
                  Excess tax benefits from employee stock plans                                             3.6                             (0.3)
                  Treasury stock acquired                                                                   (63.3)                          (71.8)
Net cash provided by (used in) financing activities                                                         1,642.7                         63.8
Effect of exchange rate changes on cash                                                                     (6.6)                           (7.7)
Net Cash Flows                                                                                              93.5                            (28.1)
Cash and Cash Equivalents:
                  At beginning of period                                                                    99.3                            127.4
                  At end of period                                                                          $                       192.8   $                         99.3

Logo - http://photos.prnewswire.com/prnh/20130123/DE47178LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hill-rom-reports-strong-fourth-quarter-and-full-year-results-exceeding-previous-guidance-300172936.html

SOURCE Hill-Rom Holdings, Inc.

http://rt.prnewswire.com/rt.gif?NewsItemId=DE48475&Transmission_Id=201511050600PR_NEWS_USPR_____DE48475&DateId=20151105



Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.